DalsnaFinance › IPOs › Metagenomi Therapeutics › IPO
Metagenomi Therapeutics, Inc. completed its initial public offering on NASDAQ on February 9, 2024, pricing at $15.00 a share.
| Ticker | MGX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 9, 2024 |
| Offering price | $15.00 |
| Shares offered | 6,250,000 |
| Total raised | $94M |
Metagenomi Therapeutics, Inc. sold 6,250,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $93.8 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $94 million total recorded for the deal.
Metagenomi Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Metagenomi Therapeutics, Inc.. This page is general information, not investment advice.